Teladoc off 3% on bottom line miss; 2024 outlook range includes consensus
by
Contributor since / Followers
Contributor since / Followers
5 months ago
Marko Geber/DigitalVision via Getty Images
- Teladoc Health (NYSE:TDOC) shares are down ~3% in after-hours trading Thursday after the telehealth provider’s Q1 2024 results missed on the bottom line. Revenue was a beat.
- In addition, the company provided full-year financial guidance. Teladoc sees revenue of $2.635B-$2.735B. Consensus is $2.66B.
- Net loss per share is projected at ($1.10) – ($0.80). Consensus is ($0.97).
- In the quarter, Teladoc (TDOC) saw its net loss widen 18% compared to the prior-year period to $81.9B. Net loss per share, basic and diluted, of ($0.49) compared to ($0.42).